FY2025 · ended Dec 31, 2025 · Revenue $143.44M, +6.4% YoY · Filed Feb 27, 2026
Infusystem Holdings, Inc (INFU) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $143.4 million and net income of $6.6 million. Free cash flow was $23.8 million. As of Jun 30, 2026 it held $964,000 in cash and investments and $24.5 million in total debt.
Revenue (TTM)
$143.34M
+2.5% vs year-ago TTM
Net income (TTM)
$8.54M
+68.4% vs year-ago TTM
Operating cash flow (TTM)
$23.37M
-12.0% vs year-ago TTM
Free cash flow (TTM)
$22.91M
-10.7% vs year-ago TTM
EPS (TTM)
$0.41
+74.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
20.22M
-3.8% vs prior year
Net cash
$-23.57M
as of Jun 30, 2026
Operating margin
9.3%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INFU (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester Hills, MI
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1337013
- Former names
- HAPC, Inc. (until Oct 30, 2007); Healthcare Acquisition Partners Corp. (until Apr 25, 2006)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M |
| Operating income | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M |
| Net income | $6.6M | $2.3M | $872,000 | $18,000 | $1.4M |
| Diluted EPS | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 |
| Operating cash flow | $24.4M | $20.5M | $11.2M | $17.5M | $18.3M |
| Free cash flow | $23.8M | $19.4M | $10.2M | $16.5M | $17.3M |
| Total assets | $100.6M | $103.6M | $102.9M | $99.4M | $97.6M |
| Total liabilities | $43.2M | $46.1M | $50.6M | $51.4M | $49.3M |
| Stockholders' equity | $57.3M | $57.5M | $52.3M | $48.0M | $48.3M |
| Cash and investments | $3.2M | $527,000 | $231,000 | $165,000 | $186,000 |
| Total debt | $24.4M | $29.9M | $36.4M | $37.8M | $37.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
All 1000 Infusystem Holdings, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.